[Cost-benefit analysis of the hepatitis B vaccination to prevent mother-to-child transmission strategies in China, 1992-2019].

Zheng, H; Wang, F Z; Zhang, G M; Miao, N; Liang, X F; Yin, Z D

Zheng, H; Wang, F Z; Zhang, G M; Miao, N; Liang, X F; Yin, Z D.

Affiliation

Zheng H; Department of National Immunization Program,Chinese Center for Disease Control and Prevention, Beijing 100050, China.
Wang FZ; Department of National Immunization Program,Chinese Center for Disease Control and Prevention, Beijing 100050, China.
Zhang GM; Department of National Immunization Program,Chinese Center for Disease Control and Prevention, Beijing 100050, China.
Miao N; Department of National Immunization Program,Chinese Center for Disease Control and Prevention, Beijing 100050, China.
Liang XF; School of Medicine Jinan University, Guangzhou 510632, China.
Yin ZD; Department of National Immunization Program,Chinese Center for Disease Control and Prevention, Beijing 100050, China.

Zhonghua Liu Xing Bing Xue Za Zhi ; 42(9): 1537-1545, 2021 Sep 10.

Article de Zh | MEDLINE | ID: mdl-34814581

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transmission verticale de maladie infectieuse / Hépatite B Type d'étude: Health_economic_evaluation / Prognostic_studies Limites: Female / Humans Pays/Région comme sujet: Asia Langue: Zh Journal: Zhonghua Liu Xing Bing Xue Za Zhi Année: 2021 Type de document: Article Pays d'affiliation: Chine Pays de publication: Chine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google